BiotechReadouts
Get updates

Pfizer (PFE): next trial readout expected around 2026-08-21

Trials that could report in the next 12 months: 18
BiopharmaCTG

Catalyst timeline

Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything PFE is running — see methodology.

  1. 2026-08-21in 2dA Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults
  2. 2026-08-23in 4dA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
  3. 2026-08-30in 2wMagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  4. 2026-08-31in 2wA Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
  5. 2026-08-31in 2wA Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
  6. 2026-09-01in 2wTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
  7. 2026-09-02in 2wA Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
  8. 2026-09-03in 2wA Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults
  9. 2026-09-10in 3wA Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults
  10. 2026-09-12in 3wA Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
  11. 2026-09-15in 4wA Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
  12. 2026-09-23in 5wStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
  13. 2026-10-09in 7wA Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
  14. 2026-10-19in 9wA Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
  15. 2026-11-29in 15wA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  16. 2026-12-02in 15wA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  17. 2026-12-02in 15wA Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
  18. 2026-12-04in 15wA Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

Pipeline

ProgramPhaseStatusPrimary completionTrial
A Study to Learn How the Body Processes the Study Medicine Called Vepd…Phase 1Recruitingstill enrolling patients2026-12-04NCT07231991
A Study to Learn About Medicine Called Ritlecitinib in Children Aged B…Phase 3Active Not Recruitingenrolled, still running2026-12-02NCT07029711
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Met…Phase 3Recruitingstill enrolling patients2026-12-02NCT06629779
A Study to Learn About the Study Medicine Called Rimegepant in Women W…Phase 3Recruitingstill enrolling patients2026-11-29NCT06641466
A Study To Learn About Two Study Medicines (PF-07275315 And PF-0726466…Phase 2Recruitingstill enrolling patients2026-10-19NCT05995964
A Study to Learn About the Study Medicine PF-07934040 When Given Alone…Phase 1Active Not Recruitingenrolled, still running2026-10-09NCT06447662
Study to Test the Safety and Tolerability of PF-07220060 in Participan…Phase 2Active Not Recruitingenrolled, still running2026-09-23NCT04557449
A Study of MET233 in Combination With MET097 in Individuals With Obesi…Phase 1Recruitingstill enrolling patients2026-09-15NCT06924320
+ 10 more tracked trials
ProgramPhaseStatusPrimary completionTrial
A Study to Learn How the Study Medicine Called Etrasimod is Taken up I…Phase 1Recruitingstill enrolling patients2026-09-12NCT07153159
A Study to Learn About How Food Affects the Uptake of Study Medicine P…Phase 1Not Yet Recruitingnot open yet2026-09-10NCT07731100
A Study to Learn How Different Forms of the Study Medicine Called PF-0…Phase 1Recruitingstill enrolling patients2026-09-03NCT07597928
A Study to Learn About the Study Medicine Called PF-07868489 in Health…Phase 1Active Not Recruitingenrolled, still running2026-09-02NCT06137742
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) W…Phase 1Active Not Recruitingenrolled, still running2026-09-01NCT05548127
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF …Phase 3Recruitingstill enrolling patients2026-08-31NCT07543380
A Study to Compare the Blood Levels of Two Dosage Formulations of the …Phase 1Recruitingstill enrolling patients2026-08-31NCT07594769
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elrana…Phase 3Recruitingstill enrolling patients2026-08-30NCT06152575
A Study to Learn About the Study Medicine (Called PF-07220060 in Combi…Phase 1Active Not Recruitingenrolled, still running2026-08-23NCT05262400
A Study to Learn How Different Amounts of the Study Medicine Called PF…Phase 1Active Not Recruitingenrolled, still running2026-08-21NCT06965465

Status-change history

Every ClinicalTrials.gov change recorded for PFE's trials — a running history no other tracker shows.

No status changes detected yet for this ticker.

Frequently asked

When is PFE's next PDUFA date?

No disclosed PDUFA date is currently tracked for this ticker.

What phase is PFE's lead program in?

Phase 3 — recruiting.

Where does this data come from?

ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.